Analyst Price Targets — PEN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 26, 2026 3:48 pm | Priya Sachdeva | UBS | $374.00 | $340.24 | StreetInsider | UBS Reiterates Neutral Rating on Penumbra (PEN) Following Q4 Results |
| February 25, 2026 7:48 pm | — | Evercore ISI | $360.00 | $338.70 | TheFly | Penumbra price target raised to $360 from $340 at Evercore ISI |
| January 20, 2026 11:34 am | — | RBC Capital | $374.00 | $350.78 | TheFly | Penumbra downgraded to Sector Perform from Outperform at RBC Capital |
| January 20, 2026 10:06 am | — | Canaccord Genuity | $374.00 | $350.78 | TheFly | Penumbra downgraded to Hold from Buy at Canaccord |
| January 16, 2026 1:55 pm | — | Jefferies | $374.00 | $350.98 | TheFly | Penumbra downgraded to Hold from Buy at Jefferies |
| January 16, 2026 7:55 am | David Rescott | Robert W. Baird | $374.00 | $350.49 | StreetInsider | Baird Downgrades Penumbra (PEN) to Neutral |
| January 16, 2026 7:12 am | Mike Kratky | Leerink Partners | $374.00 | $350.49 | StreetInsider | Leerink Partners Downgrades Penumbra (PEN) to Market Perform |
| January 16, 2026 5:46 am | Richard Newitter | Truist Financial | $374.00 | $350.49 | StreetInsider | Truist Securities Downgrades Penumbra (PEN) to Hold |
| January 15, 2026 9:12 pm | Ryan Zimmerman | BTIG | $349.00 | $350.49 | TheFly | Penumbra downgraded to Neutral from Buy at BTIG |
| January 15, 2026 4:38 pm | — | Wells Fargo | $374.00 | $351.27 | TheFly | Penumbra downgraded to Equal Weight from Overweight at Wells Fargo |
Latest News for PEN
Penumbra jumps after Q4 earnings and revenue beat, with double-digit sales growth, margin expansion and strong U.S. performance across key product lines.
Artisan Partners Limited Partnership increased its holdings in Penumbra, Inc. (NYSE: PEN) by 9.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 223,476 shares of the company's stock after purchasing an additional 19,418 shares during the period.
While the top- and bottom-line numbers for Penumbra (PEN) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Penumbra (PEN) came out with quarterly earnings of $1.18 per share, beating the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $0.97 per share a year ago.
ALAMEDA, Calif., Feb. 25, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the fourth quarter and full year ended December 31, 2025.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for PEN.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.